Neurovascular Thrombectomy Devices Market

Global Market Study on Neurovascular Thrombectomy Devices: Ischemic Stroke to drive the expansion of market

Neurovascular Thrombectomy Devices Market Segmented By Stent Retriever and Aspiration Catheter Product in Hospitals, Neuro-Catheterization Labs and Specialized Neurosurgery Centers

  • May-2022
  • PMRREP26176
  • 194 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Neurovascular Thrombectomy Devices Market Outlook (2022 - 2026)

Demand for Neurovascular Thrombectomy Devices witnessed a CAGR of 6.7% between 2013 and 2021. The global Neurovascular Thrombectomy Devices Market is expected to grow at 6.4% CAGR between 2022 and 2026. In 2022, the global Neurovascular Thrombectomy Devices Market size was US$ 655.2 million, which is projected to reach US$ 841.2 million by the year 2026.

Neurovascular Thrombectomy Devices Market Size (2022)

US$ 655.2 Mn

Projected Market Value (2026)

US$ 841.2 Mn

Global Market Growth Rate (2022-2026)

6.4% CAGR

Find Out More about the Report Coverage

Companies

  • Medtronic Plc
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Johnson & Johnson Services, Inc.
  • Penumbra Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Acandis GmbH
  • Argon Medical Inc

Neurovascular Thrombectomy Devices Market Demand Analysis (2013-2021) v/s Market Outlook (2022-2026)

Neurovascular Thrombectomy Devices Market is expected to witness a CAGR of 6.4% between 2022 and 2026. The rise in neurovascular disorders and the increasing geriatric population are contributing to the increase in demand for Neurovascular Thrombectomy Devices. Furthermore, the development of technologically sophisticated products and initiatives to raise awareness about neurovascular illnesses and their prevention are among the reasons that are anticipated to drive the market for Neurovascular Thrombectomy Devices.

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

What is expected to keep the Hopes High for Neurovascular Thrombectomy Devices Market?

  • An increase in the number of neurovascular disorders

The rise in neurovascular disorders and the increasing aging population are contributing to the increase in demand for Neurovascular Thrombectomy Devices. Furthermore, the development of technologically sophisticated products and initiatives to raise awareness about neurovascular illnesses and their prevention are among the reasons that are anticipated to drive the market for Neurovascular Thrombectomy Devices.

neurovascular-thrombectomy-devices-market

  • Increasing awareness about Ischemic Stroke and Its Prevention

Various government and non-profit groups are working to raise awareness about ischemic strokes and prevention methods. Government subsidies and supportive reimbursement policies also assist to drive market growth. Rising awareness and device acceptance will help in the market expansion of neurovascular thrombectomy devices.

  • Increasing adoption of embolic coils

The neurovascular devices market is categorized into embolic protection devices, embolic coils, intracranial stents, intrasaccular devices, and so on. Due to the rising occurrence of brain aneurysms and ischemic stroke, the embolic coils segment is expected to be in demand. For individuals who are at significant or prohibitive surgical risk, embolization coils and occlusion devices are employed to successfully eradicate the residual central aorta to the pulmonary artery. The increased need for less invasive procedures such as coil embolization will drive up future demand for embolic coils.

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

What restraints is the Neurovascular Thrombectomy Devices Market subject to?

  • “Lack of Skilled Professionals”

A key obstacle that is expected to hamper market growth is lack of competent laboratory experts. As diagnostic laboratories deploy advanced Neurovascular Thrombectomy devices and automating processes, the expansion of diagnostic laboratories is also limited by a scarcity of skilled professionals. Although the demand for medical laboratory professionals is rising, the number of new graduates from clinical laboratory programs is decreasing, limiting the market's growth.

  • “High Cost of Equipment”

The high cost of Neurovascular Thrombectomy devices is the most significant impediment to market expansion. Apart from the cost of the equipment, a significant amount of money needs to be spent on the infrastructure of a diagnostic room, particularly in developing nations. Because of the high cost of the equipment, the services are also expensive, thereby making them inaccessible to the majority of the patients in many countries. Patients from low- and middle-income countries are price-sensitive and cannot afford extremely high device costs, which is likely limit market expansion in several emerging countries.

Explore Persistence Market Research’s expertise in promulgation of the business !

How has Covid-19 affected the Neurovascular Thrombectomy Devices Market?

“Decrease in spending on system upgrades and technological advancement.”

The COVID-19 pandemic had a moderate impact on the Neurovascular Thrombectomy Devices Market because, during the pandemic, the majority of elective brain procedures were rescheduled to make room for those being treated for the virus. Moreover, as hospitals postponed elective admissions and treatments, hospital admissions began to decline in March 2020. In addition, physicians shifted away from in-person treatment toward telemedicine, and many patients had put off seeking medical aid.

Competitive Landscape

Neurovascular Thrombectomy Devices industry is very competitive and highly consolidated due to the presence of several large players. Key players in the neurovascular thrombectomy devices market are focusing on acquiring companies in order to increase their product offerings and gain a larger share of the global neurovascular thrombectomy devices market in terms of revenue.

  • NeuroVasc Technologies, Inc. treated the first patient in a Chinese Pivotal Randomized Controlled Trial to evaluate the safety and efficacy of the ENVITM-SR Mechanical Thrombectomy System (ENVITM-SR), a stent-retriever for the removal of blood clots in patients with acute ischemic stroke due to large vessel occlusion, in September 2021.
  • Terumo Medical Corporation (TMC) announced the launch of the AZUR Vascular Plug in July 2021. It is the first and only plug that can occlude arteries up to 8mm in diameter using a microcatheter. Such advanced product launches aided the company's market position.
  • Per-flow Medical, a private, Israeli-based neurovascular treatment innovator, achieved the first successful clinical usage of the StreamTM17 Dynamic Neuro-Thrombectomy Net, a lower profile device designed for more tortuous anatomy, to effectively treat hemorrhagic and ischemic stroke patients in April 2021.

Neurovascular Thrombectomy Devices Industry Report Scope

Attribute

Details

Forecast Period

2022-2026

Historical Data Available for

2013-2021

Market Analysis

US$ Mn/Bn for Value

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Key Countries Covered

  • U.S.
  • Canada
  • Germany
  • Italy
  • France
  • U.K.
  • Spain
  • Russia
  • India
  • China
  • Japan
  • UAE
  • Australia

Key Market Segments Covered

By Product

Key Companies Profiled

  • Medtronic Plc
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Johnson & Johnson Services, Inc.
  • Penumbra Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Acandis GmbH
  • Argon Medical Inc
  • Others.

Customization & Pricing

Available upon Request

Neurovascular Thrombectomy Devices Market Categorization

Neurovascular Thrombectomy Devices Market by Product

  • Stent Retriever
  • Aspiration Catheter

Neurovascular Thrombectomy Devices Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

- FAQs -

In 2022, the Neurovascular Thrombectomy Devices Market stands at USD 665.2 milion, and it is expected to reach USD 541.2 million by 2026 at a CAGR of 6.4%.

Neurovascular Thrombectomy Devices Market exhibited a 6.6% CAGR between 2013 and 2021.

High equipment cost and lack of skilled laboratory professionals are the key restraints in the Neurovascular Thrombectomy Devices Market.

An increase in the number of neurovascular disorders and increasing awareness about Ischemic Stroke and its prevention are the key factors driving the growth of the market.

Johnson & Johnson, Medtronic Plc, Stryker Corporation, and Edwards Lifesciences Corporation are among the top players in the market.

Recommendations

Heart Valve Repair and Replacement Market

The Heart Valve Repair Replacement Market is likely to have a whopping CAGR of 10.4% over the forecast period..

IV Infusion Pump Accessories Market

Global IV infusion pump accessories market reflected a value of around US$ 1.9 Bn and is expected to reach a valuation of more than US$ 2500 Mn by the 2025 end.

Hematology Analyzers Market

Global Market Study on Hematology Analyzers - collaborations with distributors, CAGR, key focus, top players & strategies that will significantly boost growth through forecast period.

ECG and EEG Testing Market

Increasing prevalence of sleep disorders and mental disorders worldwide is the main factor responsible for increase in the market of ECG & EEG testing over forecast period.

Our Clients

Our Clients